Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

Santiago Mercadal; Kwang Woo Ahn; Mariam Allbee-Johnson; Siddhartha Ganguly; Praveen Ramakrishnan Geethakumari; Sanghee Hong; Adriana Malone; Hemant Murthy; Attaphol Pawarode; Alejandro R. Sica; Melhem Solh; Celalettin Ustun; Mazyar Shadman; Craig S. Sauter; Mehdi Hamadani; Alex F. Herrera; Catherine J. Lee

doi:10.3324/haematol.2024.285613

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Letters to the Editor

Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

Santiago Mercadal
Kwang Woo Ahn
Mariam Allbee-Johnson
Siddhartha Ganguly
Praveen Ramakrishnan Geethakumari
Sanghee Hong
Adriana Malone
Hemant Murthy
Attaphol Pawarode
Alejandro R. Sica
Melhem Solh
Celalettin Ustun
Mazyar Shadman
Craig S. Sauter
Mehdi Hamadani
Alex F. Herrera
Catherine J. Lee

Utah Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI

Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY; Section of Hematology, Houston Methodist Hospital and Neal Cancer Center, Houston, TX

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL

Division of Hematology/Oncology, Department of Internal Medicine, Blood and Marrow Transplantation Program, University of Michigan Medical School, Ann Arbor, MI

Department of Hematology-Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA

Rush University Medical Center, Chicago, IL

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Hematology/Medical Oncology, Cleveland Clinic, Cleveland, OH

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

City of Hope, Duarte, CA

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Haematologica Early view Sep 5, 2024 https://doi.org/10.3324/haematol.2024.285613

Figures & Tables

Article Information

Early view : Letters to the Editor

DOI

https://doi.org/10.3324/haematol.2024.285613

Pubmed

39234871

Published

2024-09-05

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

905

PDF Downloads

330

Statistics from Altmetric.com

No Data

Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More